[D-Tyr6, ß-Ala11, Phe13, Nle14]-Bombesin (6-14) - 1 mg
- Cat.Number : AS-60134-1
 - Manufacturer Ref. :
 - 
                                Availability : 
        In stock
 
This peptide is a universal Bombesin synthetic ligand, binding to all 3 bombesin receptors. 
Bombesin is a 14-aa peptide originally isolated from the fire-bellied toad. It has two mammalian homologs, neuromedin and Gastrin-Releasing Peptide (GRP). It binds with high affinity to the GRP receptor, a member of the G-protein-coupled receptor family. It stimulates gastrin release from G cells, and acts in the brain to stop eating behavior. Bombesin is also a tumor marker for lung small cell carcinoma, neuroblastoma, pancreatic cancer and gastric cancer.
Specifications
| Chemistry | |
| Sequence one letter code | 
                                    
  | 
                        
|---|---|
| Sequence three letter code | 
                                    
  | 
                        
| Molecular Formula | 
                                    
  | 
                        
| Molecular Mass/ Weight | 
                                    
  | 
                        
| Modification | |
| Conjugation | 
                                    
  | 
                        
| Quantity & Purity | |
| Purity | 
                                     | 
                        
| Storage & stability | |
| Form | 
                                    
  | 
                        
| Storage Conditions | 
                                    
  | 
                        
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage | 
                                    
  | 
                        
| Source | |
| Source / Species | 
                                    
  | 
                        
| Codes | |
| Code Nacres | 
                                    
  | 
                        
You may also be interested in the following product(s)
            
            
            Citations
Effect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes.
Intl J Mol Med . 2015 Feb 04 ; 35(4) 925 | DOI : 10.3892/ijmm.2015.2090
- N. González
 - et al